CNBC's Melissa Lee speaks to Devon Grimme, Prometheon Pharma director of business, about a new patch that could end needle injections for people with diabetes.» Read More
Many reporters and columnists over the last couple of days have opined that baseball teams will not hesitate to do anything in their clubhouses about beer and we’ve seen that as more teams over the past couple days have decided to rid free beer from the locker rooms.Then they tell you that nothing will likely happen in the stands because beer is a huge profit maker for the teams and beer companies spend so much money on baseball that there’s a lot of politics behind doing anything more than the symbolic gesture of keeping alcohol out of the locker rooms.
The Supreme Court sided with Microsoft in a case that restricts the reach of U.S. patents overseas. The decision could impact other lawsuits against Microsoft and save the company billions because of the global scope of its operations.
If you went to bed and woke up this morning thinking the world was quiet and that today was going to be a light day at the office, you may want to call in, instead of relying on your BlackBerry. Research in Motion confirms a massive, system wide blackout affecting all its 8 million subscribers that began around 8 p.m. ET Tuesday, and while service is being restored, it is still sporadic and may take much of the day to get back on line completely.
nternet phone service provider Vonage Holdings, which was found to have infringed on three patents owned by Verizon Communications by a U.S. court, said its legal woes could lead to bankruptcy, according to a regulatory filing.
Whose story is it, anyway? By now, you may have been able to fathom that the primary function of the Breaking News Desk is to deal with -- yes, you guessed it -- breaking news. I once had a calculus teacher who, when he thought he’d made some complicated concept crystal-clear, would say, “So, the question becomes, what color is the little red schoolhouse?” Unlike the world of higher mathematics, the little schoolhouse isn’t always red at CNBC, and the Breaking News Desk doesn’t always deal with “oh-my-gosh-get-it-on-NOW!” types of stories...
A U.S. federal appeals court on Tuesday set April 24 for hearing oral arguments on Vonage Holdings' request for a stay while it appeals a finding it infringed Verizon Communications patents.
Hewlett-Packard sued computer maker Acer on Tuesday accusing the company of illegally using patented HP technology in a variety of desktops, laptops and displays sold in the U.S.
Hung up on Vonage: It’s usually easy to recognize a story worthy of our immediate attention. It’s not always so easy to answer the questions that come up from the first few dribs and drabs of information. This is one of the key minefields one must traverse in the daily business of the Breaking News Desk.
The eight-member jury assessed Vonage $58 million in past damages and ordered it to pay a 5.5% royalty rate on Vonage sales going forward.
A U.S. federal judge dismissed Alcatel-Lucent's patent claim against Microsoft over technology that converts speech into text.
The U.S. patent process takes an average 44 months -- a woefully slow rate for the rapidly evolving technology sector. That's just one of the challenges being tackled at the first-ever Technology Policy Summit in San Jose. CNBC's Silicon Valley Bureau Chief Jim Goldman reports.
The battle between software giants Microsoft and AT&T rumbles on, as Microsoft prepares to defend itself in front of the U.S. Supreme Court against AT&T’s claim that its patent has been infringed. The outcome of this latest step, which rests on a technicality involving outsourcing, will be hugely significant in the case that will make the difference of billions of dollars to the software industry.
The companies also agreed to conclude their patent litigation, which involved imaging technologies, Kodak said.
The Washington Research Foundation has sued mobile phone makers Nokia, Samsung Electronics and Matsushita-owned Panasonic for infringing on a patent for wireless Bluetooth technology.
Private generic drugmaker Ratiopharm International had challenged the patent, which led to the decision.